Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
1 hedge funds and large institutions have $1.81K invested in Exact Sciences in 2026 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
0.02% less ownership
Funds ownership: 0.02% → 0% (-0.02%)
86% less funds holding
Funds holding: 7 → 1 (-6)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $4.92M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
-$2.19M |
| 2 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$1.2M |
| 3 |
Pinkerton Retirement Specialists
Coeur D Alene,
Idaho
|
-$1.06M |
| 4 |
PWMAG
Pinnacle Wealth Management Advisory Group
Red Bank,
New Jersey
|
-$283K |
| 5 |
IFP Advisors
Tampa,
Florida
|
-$174K |
EXAS Hedge Fund Activity: Q2 2026 in Review
1 of the 8,377 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2026, worth a combined $1.81K — down 100% from $4.92M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of EXAS and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was VanEck Associates, exiting entirely with an estimated $2.19M sold.
- 1 institutional investor held Exact Sciences (EXAS) as of Q2 2026, down from 7 in Q1 2026.
- Funds reported $1.81K of Exact Sciences stock for Q2 2026, down 100% quarter-over-quarter.
- 0 funds opened new Exact Sciences positions in Q2 2026 and 6 closed out, a net change of -6 holders.
- The largest Exact Sciences seller in Q2 2026 was VanEck Associates, an estimated $2.19M sold.
Based on aggregated 13F filings for Q2 2026.